Biochemistry, Genetics and Molecular Biology
Skeletal Muscle
100%
Insulin Resistance
67%
Insulin Sensitivity
59%
Glycogen Synthase
24%
Mitochondrion
23%
Adiponectin
19%
Glucose Metabolism
18%
Lipid
16%
Cohort Study
16%
Insulin Release
15%
Cell Function
14%
Insulin Signaling
14%
Proteomics
14%
Progeny
13%
Oxidative Phosphorylation
13%
CD36
11%
Glucose Transport
10%
Body Composition
10%
Pioglitazone
10%
Lipid Droplet
10%
Tandem Mass Spectrometry
10%
Glucose Homeostasis
9%
Insulin Receptor
9%
Enzyme
8%
Aerobic Metabolism
8%
Lean Body Weight
8%
Prevalence
8%
Fat Mass
8%
Lipid Metabolism
8%
Body Mass
8%
Electrospray Ionization
8%
High-Performance Liquid Chromatography
8%
Glucose Test
8%
Glucose Tolerance Test
8%
Proteome
7%
Triglyceride
7%
Glucose Blood Level
7%
Screening
7%
Messenger RNA
7%
Receptor Gene
7%
HDL-Cholesterol
6%
Hyperglycemia
6%
Gene Expression
6%
Metabolic Pathway
6%
Phosphopeptide
6%
Mitochondrial Protein
6%
Mitochondrial Biogenesis
5%
DNA Methylation
5%
Glucagon
5%
Gluconeogenesis
5%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
69%
Insulin Sensitivity
49%
Diabetic Retinopathy
35%
Skeletal Muscle
34%
Insulin Resistance
29%
Cohort Analysis
26%
Diabetes
23%
Patient with Type 2 Diabetes
21%
Cell Function
17%
Insulin Dependent Diabetes Mellitus
17%
Cardiovascular Disease
15%
Diabetes Mellitus
14%
Androgen Therapy
14%
Beta Cell
14%
Cardiovascular Risk
10%
Insulin Release
10%
Placebo
9%
Adiponectin
9%
Screening
9%
Polycystic Ovary Syndrome
9%
Glucose Uptake
8%
Randomized Controlled Trial
8%
Oral Glucose Tolerance Test
8%
Hazard Ratio
7%
Substitution Therapy
7%
Glucose Metabolism
7%
Child
7%
Adipose Tissue
7%
Glucose Homeostasis
7%
Glycogen Synthase
7%
Mitochondrion
7%
Triacylglycerol
7%
Lean Body Weight
6%
Insulin Signaling
6%
Prevalence
6%
Body Mass Index
6%
Latent Autoimmune Diabetes in Adults
6%
Cardiovascular System
6%
Cardiometabolic Risk
6%
Aerobic Metabolism
6%
Heart Failure
6%
Birth Weight
6%
Exercise
5%
Hemoglobin A1c
5%
High Density Lipoprotein Cholesterol
5%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
56%
Diabetic Retinopathy
16%
Insulin Resistance
14%
Insulin Dependent Diabetes Mellitus
13%
Diabetes Mellitus
11%
Normal Human
10%
Metformin
9%
Glycogen Synthase
8%
Hyperinsulinemia
7%
Cohort Study
7%
Ovary Polycystic Disease
6%
Cardiovascular Disease
5%
Prevalence
5%
Heart Failure
5%
Placebo
5%
